Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon contact icon menu icon
Medicilon Logo
|
search icon close search icon contact icon menu icon
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Medicilon's News information
News information

Medicilon has been listed in the "2022 China Biopharmaceutical Innovation Billboard" for two consecutive years, and won the "Golden Horse Award - 2022 Best Preclinical CRO/CDMO Enterprise"

2023-05-12
|
Page View:

2022 best preclinical cro.webp

On April 28, 2023, the China Biopharmaceutical Industry Chain Innovation Transformation Summit and the 3rd China Biopharmaceutical Innovation Billboard Awards Ceremony were grandly opened in Nanjing, China.

Shanghai Medicilon Inc (Medicilon) stands out among many CROs in the country by virtue of advanced R&D technology, innovative service platform, outstanding performance and excellent market reputation, as a result, Medicilon is awarded the "Golden Horse Award - 2022 Best Preclinical CRO/CDMO Enterprise."

Return
Relevant newsRelevant news